Jim Al­li­son and Pam Shar­ma back a Cana­di­an AI up­start seek­ing to solve the tu­mor stro­ma puz­zle

A new com­pa­ny out of Toron­to is seek­ing to put AI and ma­chine learn­ing to the test, us­ing the ad­vanced tech­nol­o­gy to iden­ti­fy tar­gets in sol­id can­cers and oth­er chal­leng­ing dis­eases. And it has the back­ing of the in­dus­try’s res­i­dent pow­er cou­ple.

Phe­nom­ic AI of­fi­cial­ly launched Wednes­day with $6 mil­lion in seed fund­ing and an­nounced that Jim Al­li­son and Pam Shar­ma have joined its sci­en­tif­ic ad­vi­so­ry board. The biotech is al­so bring­ing on new CSO Mike Briskin, who has a pro­fes­sion­al his­to­ry with Al­li­son and Shar­ma af­ter work­ing with them and Third Rock Ven­tures to found Jounce Ther­a­peu­tics about a decade ago.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER